Skip to main content
Home
Home

Meta navigation

  • Contact
  • Donate

Main navigation

  • For patients
  • For researchers
  • About us
  • Network

Lung cancer

4 currently open clinical trials
Durvalumab in patients with advanced lung cancer and poor general state of health
SAKK 19/17
A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment in advanced malignant pleural mesothelioma
ETOP BEAT-meso
Adjuvant immunotherapy for limited-stage small cell lung cancer
ACHILES
Immunotherapy and radiotherapy in stage III non-small cell lung cancer
SAKK 16/18
All cancer types

Footer

Footer main navigation

  • For patients
  • For researchers
  • About us
  • Network

Footer Quicklinks

  • Trials
  • Events
  • News
  • Portal

Footer meta navigation

  • Contact
  • Donate
Newsletter subscription

Follow us on

  • EN
  • DE
  • FR

© 2018 SAKK - Swiss Group for Clinical Cancer Research, Effingerstrasse 33, 3008 Bern - Switzerland

Footer navigation

  • Imprint

Mobile main navigation

  • For patients
    • For patients
    • Participate in a trial
    • Genetic Counseling
    • FAQ
    • Glossary
    • Downloads
  • For researchers
    • For researchers
    • Research groups
    • Young Oncology Academy
    • Grants and fellowships
    • Electronic Data Capture (EDC)
  • About us
    • About us
    • Mission statement
    • Organization
    • Board and Executive Board
    • Patient Advisory Board
    • Support and collaborations
    • Media and publications
  • Network

Mobile meta navigation

  • Contact
  • Donate

Mobile footer navigation

  • Imprint
  • EN
  • DE
  • FR

Mobile quicklinks

  • Trials
  • Events
  • News
  • Portal

Quicklinks

  • Trials
  • Events
  • News
  • Portal